Mofecon-S 360
Mofecon-S 360 Mofecon-S 360 is an oral immunosuppressive medicine containing mycophenolic acid 360 mg in a delayed-release tablet formulation. It works by reducing the activity of certain immune cells that can attack a transplanted organ. The medicine is commonly included in anti-rejection treatment following organ transplantation and is used under specialist medical supervision.
| Brand | Mofecon-S |
| Storage Temperature | 15°C–30°C store in a cool, dry place and protect from moisture |
| Prescription Needed | Yes |
| Composition | Mycophenolic Acid |
| Strength | 360 mg |
| Form | Delayed-Release Film-Coated Tablet |
| Pack Size | 60 Tablets |
| Packaging | 6 × 10 Tablets |
| Country of Origin | Made In India |
| Manufacturer | Concord Biotech Ltd. |
Mofecon-S 360
Mofecon-S 360 Mofecon-S 360 is an oral immunosuppressive medicine containing mycophenolic acid 360 mg in a delayed-release tablet formulation. It works by reducing the activity of certain immune cells that can attack a transplanted organ. The medicine is commonly included in anti-rejection treatment following organ transplantation and is used under specialist medical supervision.
Related Products
-
-
Actemra 400 mg Injection
-
Actemra 80 mg Injection
-
Adfrar 40 mg Injection
-
CellCept 500mg
-
CellCept 250mg
-
Cibinqo 200 mg Tablets
-
Cibinqo 50 mg Tablets
-
Cibinqo 100 mg Tablets
-
Dupixent 200 mg Injection
-
Enfiera 100 mg/10 mL
-
Enfiera 500 mg/50 mL
-
Infimab 100 mg Injection
-
IPCA MMF 500
-
Litfulo 50mg Capsule
-
Mofecon 250
-
Mofecon 500
-
Mofecon 750
-
Mofecon-S 180
-
Mofecon-S 540
-
Sclerifuma 120 mg Capsules
-
Sclerifuma 240 mg Capsules
-
T-JAKI 10 mg
-
T-Jaki 5 mg
-
Tacrocord 0.5 mg
-
Tacrocord 1 mg
-
Tacrocord 0.25 mg
-
Tacrocord 2 mg
-
Tofajak 5 mg
-
Tofajak XR 11 mg